Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Hong Kong.
Press releases published on August 25, 2025
Babak Baru Kehidupan Pasien: KFSHRC Mengobati Penyakit Langka Setelah Pengobatan Khusus 22 Tahun
GlobeNewswire
·
August 25, 2025
RIYADH, Arab Saudi, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Dalam sebuah kisah langka tentang ikatan seumur hidup antara seorang pasien dan suatu lembaga kesehatan, King Faisal Specialist Hospital …
KFSHRC, 22년간 이어진 전문 진료로 희귀병 환자 치료 성공
GlobeNewswire
·
August 25, 2025
사우디아라비아 리야드, Aug. 25, 2025 (GLOBE NEWSWIRE) -- 리야드에 위치한 킹 파이살 전문병원 겸 연구센터 (KFSHRC)는 환자와 의료 기관 사이에 평생에 걸친 유대라는 드문 사례를 보여주듯, 한 환자를 영아기부터 지원해 왔으며, 희귀 유전성 혈액 응고 장애에 대해 22년간 지속적인 치료를 제공한 끝에 세계 최초로 이 질환 환자에게 간 이식을 성공적으로 시행하는데 마침내 성공했다. 환자의 생후 몇 개월 무렵 첫 번째 질환 징후가 …
新たに生まれ変わる人生： キング・ファイサル・スペシャリスト病院・研究センター (King Faisal Specialist Hospital & Research Centre、KFSHRC)、22年にわたる専門治療の末に希少疾患を治療
GlobeNewswire
·
August 25, 2025
サウジアラビア、リヤド発, Aug. 25, 2025 (GLOBE NEWSWIRE) -- 患者と医療機関の生涯にわたる絆を示す珍しい例として、リヤドのキング・ファイサル・スペシャリスト病院・研究センター (KFSHRC) は、希少な遺伝性血液凝固障害の患者を乳幼児期から支え続け、22年間にわたり継続的に治療を提供し、最終的にこの特殊な疾患では世界初となる肝臓移植を実現した。 生後数カ月で病気の初期症状が現れたとき、KFSHRCは、患者の病状を安定させるため、奔走した。 …
Transformasi Hidup: KFSHRC Berjaya Rawat Penyakit Jarang Selepas 22 Tahun Penjagaan Rapi
GlobeNewswire
·
August 25, 2025
RIYADH, Arab Saudi, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Dalam satu kisah luar biasa mengenai ikatan seumur hidup antara pesakit dan institusi penjagaan kesihatan, King Faisal Specialist Hospital …
พลิกชีวิตใหม่: KFSHRC รักษาโรคหายากสำเร็จหลังดูแลผู้ป่วยเฉพาะทางมานาน 22 ปี
GlobeNewswire
·
August 25, 2025
กรุงริยาด, ซาอุดีอาระเบีย, Aug. 25, 2025 (GLOBE NEWSWIRE) -- ในตัวอย่างความผูกพันตลอดชีวิตระหว่างผู้ป่วยและสถาบันดูแลสุขภาพที่หาได้ยาก King Faisal Specialist Hospital …
改写人生：22 年专业照护，KFSHRC 治愈罕见病
GlobeNewswire
·
August 25, 2025
利雅得，沙特阿拉伯, Aug. 25, 2025 (GLOBE NEWSWIRE) -- 在医患终生相伴的罕见案例中，利雅得 King Faisal Specialist Hospital …
重獲新生：經歷 22 年專科護理後，KFSHRC 成功治癒罕見疾病
GlobeNewswire
·
August 25, 2025
利雅德，沙地阿拉伯, Aug. 25, 2025 (GLOBE NEWSWIRE) -- 自嬰幼時期開始，利雅德的 King Faisal Specialist Hospital …
New Burnbox Updates to the 72-Hour Fasting Kit to Improve Your Experience
GlobeNewswire
·
August 25, 2025
VILNIUS, Lithuania, Aug. 25, 2025 (GLOBE NEWSWIRE) -- The 72-Hour Fasting Kit quickly became a favorite for its gut health benefits and weight loss support using science-backed products - but some users reported clumping issues when mixing the supplements. …
ENT and Allergy Associates Welcomes Ahmed Toure, MD to Its Upper West Side Clinical Team in Manhattan
GlobeNewswire
·
August 25, 2025
Tarrytown, New York, Aug. 25, 2025 (GLOBE NEWSWIRE) -- ENT and Allergy Associates, LLP (ENTA), the premier otolaryngology and allergy practice in the nation, remains committed to bringing aboard the most exceptional talent in the field of ear, nose, throat …
Oculis Appoints Mark Kupersmith, M.D., and Sebastian Wolf, M.D., Ph.D., World-Renowned Neuro-Ophthalmology and Retina Experts, as Chief Medical Advisors
GlobeNewswire
·
August 25, 2025
Mark Kupersmith, M.D. appointed as Chief Medical Advisor, Neuro-Ophthalmology, following positive Phase 2 ACUITY trial results with Privosegtor (OCS-05) in acute optic neuritis and initiation of multiple programs in neuro-ophthalmology Sebastian Wolf, M.D …
Vaxxas secures ~A$90 million in funding to commercialise needle-free vaccination delivery technology
GlobeNewswire
·
August 25, 2025
Total equity and debt raising of ~$90 million provides runway to 2H 2027 Strong support from existing and new investors including SPRIM Global Investments Funds will be used to scale-up production of needle-free vaccination delivery technology Founding CEO …
Austria and Germany to become the first markets in the European Union (EU) to launch LEQEMBI® (lecanemab)
GlobeNewswire
·
August 25, 2025
TOKYO and CAMBRIDGE, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) …
argenx Announces Positive Topline Results from ADAPT SERON Study of VYVGART in Patients with AChR-Ab Seronegative gMG
GlobeNewswire
·
August 25, 2025
Study met primary endpoint (p-value=0.0068) First global phase 3 study to demonstrate clinically meaningful improvements in disease activity across all three subtypes – MuSK+, LRP4+, triple seronegative Supplemental Biologics License Application (sBLA) to …
Valneva Announces FDA’s Decision to Suspend License of Chikungunya Vaccine IXCHIQ® in the U.S.
GlobeNewswire
·
August 25, 2025
Saint Herblain (France), August 25, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the United States Food and Drug Administration (FDA) has suspended the license for IXCHIQ®, citing four new reports …
Valneva annonce la décision de la FDA de suspendre la licence d’IXCHIQ® aux États-Unis
GlobeNewswire
·
August 25, 2025
Saint Herblain (France), le 25 août, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd’hui que l’agence de santé américaine Food and Drug Administration (FDA) a suspendu la licence d’IXCHIQ®, …
OSE Immunotherapeutics Proposes Governance Evolution and Reaffirms Strategic Priorities ahead of Annual General Meeting
GlobeNewswire
·
August 25, 2025
OSE Immunotherapeutics Proposes Governance Evolution and Reaffirms Strategic Priorities ahead of Annual General Meeting New Board Structure Reflects Balanced and Proportionate Shareholder Representation New Governance to Drive Strategic Roadmaps for Tedopi …
OSE Immunotherapeutics Propose une Evolution de sa Gouvernance et Réaffirme ses Priorités Stratégiques à l’Approche de son Assemblée Générale Annuelle
GlobeNewswire
·
August 25, 2025
OSE Immunotherapeutics Propose une Evolution de sa Gouvernance et Réaffirme ses Priorités Stratégiques à l’Approche de son Assemblée Générale Annuelle Une nouvelle structure du Conseil qui reflète une représentation équilibrée et proportionnée des …
Terumo to acquire OrganOx Limited, a leading innovator in organ preservation devices, marking strategic entry into the organ transplantation-related sector
GlobeNewswire
·
August 25, 2025
- Expanding opportunities for organ transplantation worldwide and contributing to the advancement of transplant medicine - OXFORD, United Kingdom and MADISON, N.J., Aug. 24, 2025 (GLOBE NEWSWIRE) -- Terumo Corporation (TSE: 4543, “Terumo”) today announced …
HUTCHMED Announces Appointment of Acting Chief Executive Officer
GlobeNewswire
·
August 25, 2025
HONG KONG and SHANGHAI and FLORHAM PARK, N.J, Aug. 25, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that Dr Weiguo Su, an Executive Director of the Company, will take a leave of absence from his …